Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cell survival in rat rhabdomyosarcoma tumors irradiated in vivo with extended-peak silicon ions

Journal Article · · Radiat. Res.; (United States)
DOI:https://doi.org/10.2307/3575856· OSTI ID:6325825
Cell survival curves were measured by the in vivo to in vitro assay procedure for rat rhabdomyosarcoma tumors irradiated in the distal 4-cm extended-peak region of a 670-MeV/u silicon-ion beam. RBE values determined relative to 225-kVp X rays for the killing of oxygenated tumor cells were 2.1 and 2.2 at the 1 and 10% survival levels, respectively. These RBE values are greater than those obtained previously for extended-peak carbon ions (1.7-1.8), but less than those obtained for extended-peak neon ions (2.5-2.7). This observation indicates that the RBE obtained in the distal-peak region of the 670 MeV/u silicon-ion beam lies beyond the maximum in the TBE verse LETinfinity curve for the killing of oxygenated tumor cells. The TBE value for the killing of hypoxic tumor cells in this beam was 3.6 at both the 1 and 10% survival levels. This TBE value exceeds the previously measured values for both extended-peak carbon ions (2.0) and extended-peak neon ions (3.1-3.3). OER values measured at the 1 and 10% survival levels for silicon ions were 1.2 and 1.3, respectively, compared to 1.7 for neon ions and 1.9 for carbon ions. The significant reduction in oxygen effect for accelerated silicon ions relative to the lighter elements suggests that this beam may be efficacious for the treatment of tumors whose probability of cure is limited by a large fraction of hypoxic cells.
Research Organization:
Lawrence Berkeley Lab., CA
OSTI ID:
6325825
Journal Information:
Radiat. Res.; (United States), Journal Name: Radiat. Res.; (United States) Vol. 92:1; ISSN RAREA
Country of Publication:
United States
Language:
English